Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001999371-24-011917
Filing Date
2024-09-13
Accepted
2024-09-13 17:00:19
Documents
1
Period of Report
2024-10-30

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT tnxp-pre14a_103024.htm PRE 14A 188708
  Complete submission text file 0001999371-24-011917.txt   189862
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36019 | Film No.: 241298477
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)